Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Contextual challenges in implementing artificial intelligence for healthcare in low-resource environments: insights from the SPEC-AI Nigeria trial
4
Zitationen
27
Autoren
2025
Jahr
Abstract
Nigeria is the most populous country in Africa with the highest gross domestic product (GDP) as of 2022. However, Nigeria is burdened by significant health challenges including an extremely high maternal mortality ratio, inadequate human resources, poor healthcare infrastructure, and population-level poverty rates as high as 40%. Nigeria also has the highest reported prevalence of peripartum cardiomyopathy worldwide which contributes to maternal mortality. Unfortunately, the diagnosis of peripartum cardiomyopathy is often delayed and mortality rates following diagnosis are extremely high (approximately 50%). Thus, there is a huge unmet need for simple, effective, and accessible solutions for cardiomyopathy detection in this population. To address maternal mortality through screening and early diagnosis, we designed and conducted a randomized controlled clinical trial (NCT05438576) of an artificial intelligence (AI) technology in Nigeria. The objective of the study was to evaluate the impact of AI-guided screening on cardiomyopathy detection in obstetric patients. The study findings showed AI-guided screening doubled the detection of cardiomyopathy (defined as left ventricular ejection fraction <50%) when compared to usual care with a number needed to screen of 47. As we explore next steps in relation to deploying this technology for clinical use in Nigeria, we sought to gather contextual information and broadly share lessons learned from the recently completed trial. To that end, we convened a round table discussion with all study site investigators aimed at identifying site-specific contextual challenges related to the development and conduct of the study. The SPEC-AI Nigeria study is the first published randomized controlled clinical trial of a health AI intervention in Nigeria. Insights gained from this study can inform future AI intervention studies in clinical care, guide the development of implementation strategies to ensure effective interventions are successfully incorporated into clinical care, and provide a roadmap for key stakeholders to consider when evaluating AI-technologies for use in low-resource settings.
Ähnliche Arbeiten
Heart Disease and Stroke Statistics—2012 Update
2011 · 7.220 Zit.
2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
2015 · 6.912 Zit.
The incidence of congenital heart disease
2002 · 6.008 Zit.
Burden of valvular heart diseases: a population-based study
2006 · 4.743 Zit.
Updated Clinical Classification of Pulmonary Hypertension
2013 · 4.179 Zit.
Autoren
- Demilade Adedinsewo
- Damilola Onietan
- Andrea Carolina Morales-Lara
- Shiraz Sheriff
- Bosede Bukola Afolabi
- Oyewole A. Kushimo
- Amam Mbakwem
- Kehinde F. Ibiyemi
- James Ayodele Ogunmodede
- Hadijat Olaide Raji
- Sadiq Hassan Ringim
- Abdullahi A. Habib
- Sabiu M. Hamza
- Okechukwu S. Ogah
- Gbolahan Obajimi
- Olugbenga Oluseun Saanu
- Solomon Aborisade
- Olusoji Jagun
- Francisca Inofomoh
- Temitope Adeolu
- Kamilu M. Karaye
- Sule Abdullahi Gaya
- Yahya Sa’ad
- Isiaka Alfa
- Cynthia Yohanna
- Peter A. Noseworthy
- Rickey E. Carter
Institutionen
- Mayo Clinic in Florida(US)
- WinnMed(US)
- University of Lagos(NG)
- Lagos University Teaching Hospital(NG)
- University of Ilorin Teaching Hospital(NG)
- University of Ilorin(NG)
- University of Ibadan(NG)
- University College Hospital, Ibadan(NG)
- Olabisi Onabanjo University Teaching Hospital(NG)
- Olabisi Onabanjo University(NG)
- Bayero University Kano(NG)
- Aminu Kano Teaching Hospital(NG)
- Mayo Clinic in Arizona(US)